ABIVAX AAVXF Stock
ABIVAX Price Chart
ABIVAX AAVXF Financial and Trading Overview
| ABIVAX stock price | 80.03 USD |
| Previous Close | 139 USD |
| Open | 90.45 USD |
| Bid | 84.81 USD x 10000 |
| Ask | 89.81 USD x 10000 |
| Day's Range | 80.03 - 90.45 USD |
| 52 Week Range | 71.26 - 139 USD |
| Volume | 500 USD |
| Avg. Volume | 0 USD |
| Market Cap | 6.98B USD |
| Beta (5Y Monthly) | -0.232 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -6.08 USD |
| Forward Dividend & Yield | N/A (0%) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
AAVXF Valuation Measures
| Enterprise Value | 10.69B USD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 1496.2169 |
| Price/Book (mrq) | 15.570035 |
| Enterprise Value/Revenue | 2290.789 |
| Enterprise Value/EBITDA | -36.678 |
Trading Information
ABIVAX Stock Price History
| Beta (5Y Monthly) | -0.232 |
| 52-Week Change | 43.72% |
| S&P500 52-Week Change | 17.38% |
| 52 Week High | 139 USD |
| 52 Week Low | 71.26 USD |
| 50-Day Moving Average | 139 USD |
| 200-Day Moving Average | 122.41 USD |
AAVXF Share Statistics
| Avg. Volume (3 month) | 0 USD |
| Avg. Daily Volume (10-Days) | 0 USD |
| Shares Outstanding | 87.27M |
| Float | 62.47M |
| Short Ratio | N/A |
| % Held by Insiders | 3.85% |
| % Held by Institutions | 52.57% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | N/A |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | June 30, 2026 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -8617.93% |
| Gross Margin | 100.00% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -62.88% |
| Return on Equity (ttm) | -252.34% |
Income Statement
| Revenue (ttm) | 4.67M USD |
| Revenue Per Share (ttm) | 0.06 USD |
| Quarterly Revenue Growth (yoy) | -6.80% |
| Gross Profit (ttm) | 4.67M USD |
| EBITDA | -291548992 USD |
| Net Income Avi to Common (ttm) | -401217984 USD |
| Diluted EPS (ttm) | -6.08 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 402.38M USD |
| Total Cash Per Share (mrq) | 5.04 USD |
| Total Debt (mrq) | 1.21M USD |
| Total Debt/Equity (mrq) | 0.33 USD |
| Current Ratio (mrq) | 5.965 |
| Book Value Per Share (mrq) | 5.1400013 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -197020000 USD |
| Levered Free Cash Flow (ttm) | -125898128 USD |
Profile of ABIVAX
| Country | United States |
| State | N/A |
| City | Paris |
| Address | 7-11 Boulevard Haussmann |
| ZIP | 75009 |
| Phone | 33 1 53 83 09 63 |
| Website | https://www.abivax.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 98 |
ABIVAX Société Anonyme, a clinical-stage biotechnology company, develops therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. Its lead drug candidate includes obefazimod, which is in Phase 3 clinical development for the treatment of moderately to severely active UC, as well as Phase 2b clinical trials for Crohn's disease. The company was incorporated in 2013 and is headquartered in Paris, France.
Q&A For ABIVAX Stock
What is a current AAVXF stock price?
ABIVAX AAVXF stock price today per share is 80.03 USD.
How to purchase ABIVAX stock?
You can buy AAVXF shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for ABIVAX?
The stock symbol or ticker of ABIVAX is AAVXF.
Which industry does the ABIVAX company belong to?
The ABIVAX industry is Biotechnology.
How many shares does ABIVAX have in circulation?
The max supply of ABIVAX shares is 87.27M.
What is ABIVAX Price to Earnings Ratio (PE Ratio)?
ABIVAX PE Ratio is now.
What was ABIVAX earnings per share over the trailing 12 months (TTM)?
ABIVAX EPS is -6.08 USD over the trailing 12 months.
Which sector does the ABIVAX company belong to?
The ABIVAX sector is Healthcare.
